一般財団法人化学及血清療法研究所において製造販売される血液製剤について ｜報道発表資料｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000088175.htmlThe evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
一般財団法人化学及血清療法研究所において製造販売される血液製剤について ｜報道発表資料｜厚生労働省
Open the archived HTML with saved-time metadata attached.
This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.
This page is a Ministry of Health, Labour and Welfare press release regarding blood products manufactured by the General Incorporated Foundation Institute for Serum and Vaccine Research (Kaketsuken). Twelve products with 26 items were found to be manufactured using methods different from those approved, including unapproved heparin addition, different additive quantities, and altered manufacturing processes. While serious health risks are considered low, the ministry has halted shipments and instructed the institute to apply for approval modifications. For six products with no alternatives, shipments are exceptionally permitted after safety confirmation.
